Topic:

Partnering

Latest Headlines

Latest Headlines

Astellas leans on U.K. luminaries for cancer R&D

Japanese drugmaker Astellas Pharma has teamed up with Cancer Research U.K. to join forces on early-stage oncology R&D, working to identify new treatments for pancreatic cancer.

GlaxoSmithKline backs off from Galapagos' anti-inflammatory hopeful

GlaxoSmithKline has again scaled back its expectations for an anti-inflammatory treatment licensed from Galapagos, calling off any plans for late-stage study after a few Phase II miscues dulled the drug's potential.

Quintiles and Roche take to China with testing partnership

Quintiles has signed a deal with a Roche diagnostics subsidiary to offer cancer screenings in China, looking to capitalize on the growing market for clinical trials in the country.

Roche, Quintiles partner for companion diagnostics in China

Ventana and Quintiles are partnering up to provide companion diagnostic testing services in China for early clinical trials. China is among a few countries that requires patient samples used in clinical trials to be tested domestically for inclusion in the country's approval process.

Daiichi Sankyo bets up to $650M on Charleston's pain potential

Daiichi Sankyo, Japan's second-largest pharma outfit, has agreed to pay up to $650 million to get its hands on some hydrocodone combo medications, striking a deal with Charleston Laboratories with hopes of cashing in on the demand for pain pills.

Siemens and Cerner team to develop new med tech as part of $1.3B deal

Siemens and Cerner are teaming up to develop medical devices, imaging and healthcare technology as part of Cerner's $1.3 billion acquisition of Siemens' health information technology business.

Boehringer walks away from an anti-inflammatory deal with Orexo

Boehringer Ingelheim has handed back the rights to a drug development project targeting pain and inflammation, ending a long-standing partnership with Orexo.

Philips, Accenture create brain wave app for immobilized patients

As part of a broader mandate for Philips to make itself more relevant in healthcare, Royal Philips and Accenture have created proof-of-concept software to enable anyone with limited muscle or speech function to better interact with the world around them.

Columbia Labs partners up for preclinical services

Columbia Laboratories has struck a deal with CRO XenoGesis to team up on preclinical research, pooling their resources to offer tandem early-phase services.

Venrock unveils a $450M new fund with eyes on biotech

Well-heeled venture capital firm Venrock has pieced together a 7th fund, banking $450 million in new investments as it sets out to grow its portfolio of promising startups.